These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 7781792)

  • 1. Effect of essential fatty acids on natural cytotoxicity in patients with colorectal cancer.
    Purasiri P; Ashby J; Heys SD; Eremin O
    Eur J Surg Oncol; 1995 Jun; 21(3):254-60. PubMed ID: 7781792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distal procto-colitis, natural cytotoxicity, and essential fatty acids.
    Almallah YZ; Richardson S; O'Hanrahan T; Mowat NA; Brunt PW; Sinclair TS; Ewen S; Heys SD; Eremin O
    Am J Gastroenterol; 1998 May; 93(5):804-9. PubMed ID: 9625132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation in vitro of human natural cytotoxicity, lymphocyte proliferative response to mitogens and cytokine production by essential fatty acids.
    Purasiri P; Mckechnie A; Heys SD; Eremin O
    Immunology; 1997 Oct; 92(2):166-72. PubMed ID: 9415022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of essential fatty acids on circulating T cell subsets in patients with colorectal cancer.
    Purasiri P; Ashby J; Heys SD; Eremin O
    Cancer Immunol Immunother; 1994 Oct; 39(4):217-22. PubMed ID: 7954523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-2 (IL-2) augments host cellular immune reactivity in the perioperative period in patients with malignant disease.
    Deehan DJ; Heys SD; Ashby J; Eremin O
    Eur J Surg Oncol; 1995 Feb; 21(1):16-22. PubMed ID: 7851545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The presence and cytotoxicity of CD16+ CD2- subset from PBL and NK cells in long-term IL-2 cultures enhanced by Prothymosin-alpha.
    Cordero OJ; Sarandeses C; López-Rodríguez JL; Nogueira M
    Immunopharmacology; 1995 Apr; 29(3):215-23. PubMed ID: 7542644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a novel CD56- lymphokine-activated killer cell precursor in cancer patients receiving recombinant interleukin 2.
    McKenzie RS; Simms PE; Helfrich BA; Fisher RI; Ellis TM
    Cancer Res; 1992 Nov; 52(22):6318-22. PubMed ID: 1384959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo induction of lymphokine-activated killer cells by interleukin-2 splenic artery perfusion in advanced malignancy.
    Klasa RJ; Silver HK; Kong S
    Cancer Res; 1990 Aug; 50(16):4906-10. PubMed ID: 2379154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. VLA-6 (CDw49f) is an important adhesion molecule in NK cell-mediated cytotoxicity following autologous or allogeneic bone marrow transplantation.
    Lowdell MW; Shamim F; Hamon M; Macdonald ID; Prentice HG
    Exp Hematol; 1995 Dec; 23(14):1530-4. PubMed ID: 8542943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of prolactin in the modulation of NK and LAK cell activity after short- or long-term morphine administration in neoplastic patients.
    Provinciali M; Di Stefano G; Stronati S; Raffaeli W; Pari G; Fabris N
    Int J Immunopharmacol; 1996 Oct; 18(10):577-86. PubMed ID: 9080251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel multiparametric flow cytometry-based cytotoxicity assay simultaneously immunophenotypes effector cells: comparisons to a 4 h 51Cr-release assay.
    Kim GG; Donnenberg VS; Donnenberg AD; Gooding W; Whiteside TL
    J Immunol Methods; 2007 Aug; 325(1-2):51-66. PubMed ID: 17617419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural killer (NK) and lymphokine-activated killer (LAK) activities in a patient who recovered from cancer, and the characteristics of LAK cells generated from CD4-CD8- and CD8+ peripheral blood lymphocytes.
    Komatsu F; Kihara K
    Clin Immunol Immunopathol; 1995 Oct; 77(1):75-81. PubMed ID: 7554487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced LAK cytotoxicity of peripheral blood mononuclear cells in patients with bladder cancer: decreased LAK cytotoxicity caused by a low incidence of CD56+ and CD57+ mononuclear blood cells.
    Hermann GG; Petersen KR; Steven K; Zeuthen J
    J Clin Immunol; 1990 Nov; 10(6):311-20. PubMed ID: 1707414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibrin formation inhibits the in vitro cytotoxic activity of human natural and lymphokine-activated killer cells.
    Gunji Y; Lewis J; Gorelik E
    Blood Coagul Fibrinolysis; 1990 Dec; 1(6):663-72. PubMed ID: 2133246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Swainsonine, a glycosylation inhibitor, enhances both lymphocyte efficacy and tumour susceptibility in LAK and NK cytotoxicity.
    Galustian C; Foulds S; Dye JF; Guillou PJ
    Immunopharmacology; 1994; 27(2):165-72. PubMed ID: 7516929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated prostaglandin E2 production by monocytes is responsible for the depressed levels of natural killer and lymphokine-activated killer cell function in patients with breast cancer.
    Baxevanis CN; Reclos GJ; Gritzapis AD; Dedousis GV; Missitzis I; Papamichail M
    Cancer; 1993 Jul; 72(2):491-501. PubMed ID: 8319179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic action of a plant rhamnogalacturonan enhancing antitumor cytotoxicity of human natural killer and lymphokine-activated killer cells: chemical specificity of target cell recognition.
    Mueller EA; Anderer FA
    Cancer Res; 1990 Jun; 50(12):3646-51. PubMed ID: 1692765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LAK-cell-mediated cytotoxicity against tumor cell targets used to monitor the stimulatory effect of interleukin-2: cytotoxicity, target recognition and phenotype of effector cells lysing the Daudi, T24 and K562 tumor cell lines.
    Hermann GG; Zeuthen J; Claësson MH
    Nat Immun; 1992; 11(1):7-16. PubMed ID: 1611282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human lymphokine-activated killer cells are cytotoxic against cells infected with Toxoplasma gondii.
    Subauste CS; Dawson L; Remington JS
    J Exp Med; 1992 Dec; 176(6):1511-9. PubMed ID: 1460415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NK and LAK activities from human marrow progenitors. I. The effects of interleukin-2 and interleukin-1.
    Keever CA; Pekle K; Gazzola MV; Collins NH; Gillio A
    Cell Immunol; 1990 Mar; 126(1):211-26. PubMed ID: 1689220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.